Cargando…
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial
OBJECTIVE: To assess if 12 novel circulating biomarkers, when added to ‘standard predictors’ available in general practice, could improve the 10-year prediction of cardiovascular events and mortality in patients with stable coronary heart disease. DESIGN: The patients participated as placebo receivi...
Autores principales: | Winkel, Per, Jakobsen, Janus Christian, Hilden, Jørgen, Jensen, Gorm Boje, Kjøller, Erik, Sajadieh, Ahmad, Kastrup, Jens, Kolmos, Hans Jørn, Iversen, Kasper Karmark, Bjerre, Mette, Larsson, Anders, Ärnlöv, Johan, Gluud, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443269/ https://www.ncbi.nlm.nih.gov/pubmed/32819979 http://dx.doi.org/10.1136/bmjopen-2019-033720 |
Ejemplares similares
-
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
por: Winkel, Per, et al.
Publicado: (2017) -
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study
por: Nilsson, Erik, et al.
Publicado: (2020) -
10‐Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy
por: Carlsson, Axel C., et al.
Publicado: (2018) -
Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course
por: Winkel, Per, et al.
Publicado: (2018) -
Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)